OncLive® On Air

514 Folgen

1. S14 Ep18: Patient Characteristics and Disease Factors Guide the Use of Dostarlimab in Recurrent Endometrial Cancer: With Dana M. Chase, MD

   Vom: 17.9.2025
2. S14 Ep17: Expert Guidance on Frequently Asked Questions Regarding the Use of ADCs in TNBC

   Vom: 16.9.2025
3. S14 Ep16: Establishing the Rationale for ADC and ICI Combinations in TNBC

   Vom: 16.9.2025
4. S14 Ep15: Cohort Analysis Shows Importance of Early-Onset CRC Awareness and Investigation: With Evelyn Y. Wong, MD

   Vom: 15.9.2025
5. S14 Ep14: Expert Roundtable and Panel Discussions: Current and Future Landscape of TNBC

   Vom: 15.9.2025
6. S14 Ep13: Dissecting Clinical Trial and Real-World Data for ADCs in TNBC

   Vom: 15.9.2025
7. S14 Ep12: Evaluating the Latest Data and Ongoing Trials for Novel ADC Approaches in TNBC

   Vom: 12.9.2025
8. S14 Ep11: Breaking Down the Rationale for Targeting TROP2 in TNBC

   Vom: 12.9.2025
9. S14 Ep10: Patient Characteristics and Care Team Collaboration Influence Treatment Decision-Making in CLL: With John N. Allan, MD; and Melissa Rubianes

   Vom: 11.9.2025
10. S14 Ep9: Tepotinib Efficacy and Safety Profiles Underscore the Importance of Biomarker-Directed Decision-Making in NSCLC: With Balazs Halmos, MD, MS

    Vom: 9.9.2025
11. S14 Ep8: Recent FDA Approvals and Ongoing Research Expand Treatment Options for Soft Tissue Sarcoma: With Samantha A. Armstrong, MD; and Karine Tawagi, MD

    Vom: 8.9.2025
12. S14 Ep7: Clinical Trial and Real-World Data With NALIRIFOX Shape the Future of Pancreatic Cancer Care: With Tara E. Seery, MD; Paul E. Oberstein, MD; and Priyadarshini Pathak, MBBS

    Vom: 4.9.2025
13. S14 Ep6: Advances in ctDNA Testing Guide Clinical Decision-Making in GI Cancer Management: With Scott Kopetz, MD, PhD, FACP

    Vom: 3.9.2025
14. S14 Ep5: Safety and Quality-of-Life Considerations Shape ADT Use in Prostate Cancer: With Tanya B. Dorff, MD

    Vom: 2.9.2025
15. S14 Ep4: FDA Approval Insights: Dordaviprone in H3K27M-Mutated Diffuse Midline Glioma: With Patrick Y. Wen, MD

    Vom: 1.9.2025
16. S14 Ep3: FDA Approval Insights: Taletrectinib in ROS1+ Advanced/Metastatic NSCLC: With Joel Neal, MD, PhD; and Christian Rolfo, MD, PhD

    Vom: 28.8.2025
17. S14 Ep2: FDA Approval Insights: Zongertinib in HER2-Mutated NSCLC: With Ticiana Leal, MD, and Misako Nagasaka, MD, PhD

    Vom: 27.8.2025
18. S14 Ep1: Obe-Cel Data Are Poised to Refine and Expand the ALL Treatment Paradigm: With Aaron Logan, MD, PhD; and Bijal Shah, MD, MS

    Vom: 26.8.2025
19. S13 Ep50: SUPRAME Trial Propels the Development of TCR-Based Therapy in Cutaneous Melanoma: With Jason Luke, MD

    Vom: 25.8.2025
20. S13 Ep49: Distinguishing Pathway to Precision for c-Met and MET Alterations in NSCLC

    Vom: 22.8.2025